A Poison Pill is a shareholder rights plan adopted by a company’s board to deter hostile takeovers by making an acquisition prohibitively expensive (often by allowing existing shareholders to buy discounted shares if a bidder crosses an ownership threshold). In public-company M&A, a Poison Pill is a defensive tool that can buy time and force negotiations, and Poison Pill adoption can trigger investor scrutiny and litigation risk.
